{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:32:18Z","timestamp":1792895538808,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004343","name":"3M","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.imbio.2023.152356","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T21:37:31Z","timestamp":1677015451000},"page":"152356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effects of PFOS and cyclophosphamide exposure on immune homeostasis in mice"],"prefix":"10.1016","volume":"228","author":[{"given":"Timothy M.","family":"Pierpont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Limper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Elmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amie","family":"Redko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orchi","family":"Anannya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Imbiakha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanis","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Anronikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narda","family":"Bondah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Sahler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avery","family":"August","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2023.152356_b0005","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00280-016-3152-1","article-title":"The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy","volume":"78","author":"Ahlmann","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.imbio.2023.152356_b0010","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ieam.258","article-title":"Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins","volume":"7","author":"Buck","year":"2011","journal-title":"Integr. Environ. Assess. Manag."},{"key":"10.1016\/j.imbio.2023.152356_b0015","unstructured":"CDC. Fourth National Report on Human Exposure to Environmental Chemicals. (2019)."},{"key":"10.1016\/j.imbio.2023.152356_b0020","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3389\/fimmu.2013.00508","article-title":"The DNA damage response: a common pathway in the regulation of NKG2D and DNAM-1 ligand expression in normal, infected, and cancer cells","volume":"4","author":"Cerboni","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2023.152356_b0025","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.reprotox.2011.07.002","article-title":"Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys","volume":"33","author":"Chang","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.imbio.2023.152356_b0030","first-page":"387","article-title":"Evaluation of serum lipid, thyroid, and hepatic clinical chemistries in association with serum perfluorooctanesulfonate (PFOS) in cynomolgus monkeys after oral dosing with potassium PFOS","volume":"156","author":"Chang","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.imbio.2023.152356_b0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/10408444.2015.1122573","article-title":"A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humans","volume":"46","author":"Chang","year":"2016","journal-title":"Crit. Rev. Toxicol."},{"issue":"1-2","key":"10.1016\/j.imbio.2023.152356_b0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tox.2007.01.020","article-title":"Negative bias from analog methods used in the analysis of free thyroxine in rat serum containing perfluorooctanesulfonate (PFOS)","volume":"234","author":"Chang","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.imbio.2023.152356_b0045","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/etc.4935","article-title":"PFAS exposure pathways for humans and wildlife: a synthesis of current knowledge and key gaps in understanding","volume":"40","author":"De Silva","year":"2021","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.imbio.2023.152356_b0050","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00204-009-0424-0","article-title":"Chronic effects of perfluorooctanesulfonate exposure on immunotoxicity in adult male C57BL\/6 mice","volume":"83","author":"Dong","year":"2009","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.imbio.2023.152356_b0055","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00204-011-0661-x","article-title":"Sub-chronic effect of perfluorooctanesulfonate (PFOS) on the balance of type 1 and type 2 cytokine in adult C57BL6 mice","volume":"85","author":"Dong","year":"2011","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.imbio.2023.152356_b0060","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.taap.2012.08.010","article-title":"Induction of p53-mediated apoptosis in splenocytes and thymocytes of C57BL\/6 mice exposed to perfluorooctane sulfonate (PFOS)","volume":"264","author":"Dong","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.imbio.2023.152356_b0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/1547691X.2010.527868","article-title":"Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B6C3F1 mice","volume":"8","author":"Fair","year":"2011","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.imbio.2023.152356_b0070","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/toxsci\/kfm053","article-title":"Exposure to the immunosuppressant, perfluorooctanoic acid, enhances the murine IgE and airway hyperreactivity response to ovalbumin","volume":"97","author":"Fairley","year":"2007","journal-title":"Toxicol. Sci. Off. J. Soc. Toxicol."},{"key":"10.1016\/j.imbio.2023.152356_b0075","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1158\/0008-5472.CAN-05-4603","article-title":"The DNA damage response arouses the immune system","volume":"66","author":"Gasser","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.imbio.2023.152356_b0080","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/archsurg.1975.01360180043009","article-title":"Pseudomonas aeruginosa infection in mice after treatment with cyclophosphamide","volume":"110","author":"Grogan","year":"1975","journal-title":"Arch. Surg."},{"key":"10.1016\/j.imbio.2023.152356_b0085","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1002\/etc.5182","article-title":"Environmental sources, chemistry, fate, and transport of per- and polyfluoroalkyl substances: state of the science, key knowledge gaps, and recommendations presented at the August 2019 SETAC Focus Topic Meeting","volume":"40","author":"Guelfo","year":"2021","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.imbio.2023.152356_b0090","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2131\/jts.34.687","article-title":"Effect of perfluorooctane sulfonate (PFOS) on influenza A virus-induced mortality in female B6C3F1 mice","volume":"34","author":"Guruge","year":"2009","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.imbio.2023.152356_b0095","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/oemed-2017-104651","article-title":"Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water","volume":"75","author":"Li","year":"2018","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.imbio.2023.152356_b0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/toxsci\/kfn113","article-title":"Evaluation of the immune system in rats and mice administered linear ammonium perfluorooctanoate","volume":"105","author":"Loveless","year":"2008","journal-title":"Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.imbio.2023.152356_b0105","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.bbmt.2016.12.640","article-title":"Post-transplantation cyclophosphamide after bone marrow transplantation is not associated with an increased risk of donor-derived malignancy","volume":"23","author":"Majzner","year":"2017","journal-title":"Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant."},{"key":"10.1016\/j.imbio.2023.152356_b0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1620\/tjem.162.147","article-title":"Differential effects of a single dose of cyclophosphamide on T cell subsets of the thymus and spleen in mice: flow cytofluorometry analysis","volume":"162","author":"Miyauchi","year":"1990","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.imbio.2023.152356_b0115","unstructured":"NHANES. Early Release: Per- and Polyfluorinated Substances (PFAS) Tables. (2011)."},{"key":"10.1016\/j.imbio.2023.152356_b0120","unstructured":"National Toxicology Program (NTP). NTP Monograph. Immunotoxicity Associated with Exposure to Perfuorooctanoic Acid or Perfuorooctane Sulfonate. National Institute of Environmental Health Sciences, National Institutes of Health. U.S. Department of Health and Human Services. https:\/\/ntp.niehs.nih.gov\/whatwestudy\/assessments\/noncancer\/completed\/pfoa\/index.html."},{"key":"10.1016\/j.imbio.2023.152356_b0125","unstructured":"OECD. Hazard Assessment of Perfluorooctane Sulfonate (PFOS) and Its Salts. (2002)."},{"key":"10.1016\/j.imbio.2023.152356_b0130","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1289\/ehp.10009","article-title":"Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers","volume":"115","author":"Olsen","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.imbio.2023.152356_b0135","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00043764-199909000-00012","article-title":"Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees","volume":"41","author":"Olsen","year":"1999","journal-title":"J. Occup. Environ. Med."},{"key":"10.1016\/j.imbio.2023.152356_b0140","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/toxsci\/kfn059","article-title":"Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate","volume":"104","author":"Peden-Adams","year":"2008","journal-title":"Toxicol. Sci."},{"issue":"1-3","key":"10.1016\/j.imbio.2023.152356_b0145","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tox.2009.03.009","article-title":"The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPAR\u03b1)","volume":"260","author":"Qazi","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.imbio.2023.152356_b0150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41370-018-0094-1","article-title":"A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects","volume":"29","author":"Sunderland","year":"2019","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"10.1016\/j.imbio.2023.152356_b0155","doi-asserted-by":"crossref","unstructured":"Torres, L., et al., 2020. Effect of Perfluorooctanesulfonic acid (PFOS) on immune cell development and function in mice. bioRxiv 2020.01.20.913293 (2020) doi:10.1101\/2020.01.20.913293.","DOI":"10.1101\/2020.01.20.913293"},{"key":"10.1016\/j.imbio.2023.152356_b0160","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/1091581818780128","article-title":"Effect of cyclophosphamide treatment on central and effector memory T cells in mice","volume":"37","author":"W\u0142odarczyk","year":"2018","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.imbio.2023.152356_b0165","doi-asserted-by":"crossref","first-page":"77004","DOI":"10.1289\/EHP6785","article-title":"Serum half-lives for short- and long-chain perfluoroalkyl acids after ceasing exposure from drinking water contaminated by firefighting foam","volume":"128","author":"Xu","year":"2020","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.imbio.2023.152356_b0170","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijbiomac.2013.12.029","article-title":"Chemoprotective effects of Ganoderma atrum polysaccharide in cyclophosphamide-induced mice","volume":"64","author":"Yu","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.imbio.2023.152356_b0175","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.envint.2019.03.002","article-title":"Assessing the human health risks of perfluorooctane sulfonate by in vivo and in vitro studies","volume":"126","author":"Zeng","year":"2019","journal-title":"Environ. Int."},{"key":"10.1016\/j.imbio.2023.152356_b0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/1547691X.2012.691123","article-title":"Mechanism of perfluorooctanesulfonate (PFOS)-induced apoptosis in the immunocyte","volume":"10","author":"Zhang","year":"2013","journal-title":"J. Immunotoxicol."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298523000244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298523000244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:50:11Z","timestamp":1759251011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298523000244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0171298523000244"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2023.152356","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of PFOS and cyclophosphamide exposure on immune homeostasis in mice","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2023.152356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"152356"}}